Occam Recruits Chief Commercial Officer at Geron
In September 2024, Occam Global recruited Jim Ziegler as Chief Commercial Officer of Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical oncology company.
In this role, Ziegler will spearhead the company’s global commercial strategy and operations and drive the growth of RYTELO™, Geron’s first marketed product.
Ziegler has over 25 years of commercial experience in the biopharmaceutical industry, spanning strategic and operational leadership roles in large and smaller organizations.
Ziegler joins Geron from Iovance Biotherapeutics (Nasdaq:IOVA), where he served as Executive Vice President of Commercial, with global responsibilities for the company’s novel autologous cell therapy program and led the U.S. commercial launch of Amtagvi™. Previously, he served in numerous commercial leadership roles at Gilead, Biogen, Amgen, and Pfizer.
Prior to the biopharmaceutical industry, Jim honorably served his country as an Armor Officer in the U.S. Army. Ziegler received a B.S. from the United States Military Academy at West Point and an M.B.A. from the University of Chicago.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.